Dec 19 (Reuters) - Bristol-Myers Squibb Co BMY.N received
an offer from Japanese healthcare firm Taisho Pharmaceutical
Holdings Co Ltd 4581.T to buy the company's French
over-the-counter drugs business UPSA for $1.6 billion, the
companies said on Wednesday.
The offer by Taisho is structured in the form of a "put
option" agreement, the companies said. urn:newsml:reuters.com:*:nBw4XRLDha
Bristol-Myers said it estimates the potential deal would be
approximately $0.04 dilutive to 2019 earnings.
(Reporting by Rama Venkat in Bengaluru; Editing by Sunil Nair)
((ramavenkat.raman@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 7151; Reuters Messaging:
ramavenkat.raman.thomsonreuters.com@reuters.net))